Novartis India Shares Soar on $159M Exit Deal

Shares Surge on Acquisition Announcement

Shares of Novartis India surged by 20%, hitting the upper circuit limit after its Swiss parent company, Novartis AG, announced an agreement to sell its entire 70.68% stake. The deal, valued at approximately 14.46 billion rupees or $159 million, is part of the global drugmaker's strategy to streamline its operations.

Transaction Overview

A consortium led by ChrysCapital affiliates, including WaveRise Investments and Two null Partners, will acquire the majority stake from Novartis AG. The transaction involves a share purchase agreement where the buyers will pay up to $159 million. This move will transfer full control of the publicly listed Indian entity to the ChrysCapital-led group, marking a complete exit for Novartis AG as a promoter and owner.

Market Impact and Next Steps

Following the initial stake acquisition, the new owners will launch a mandatory open offer to purchase an additional 26% of shares from public investors at 860.64 rupees per share. If fully subscribed, this could increase the consortium's total holding to approximately 96.7%. The completion of the sale is still subject to standard regulatory clearances and other closing conditions.

Summary

The market has responded with strong positivity to the news of the acquisition, as evidenced by the significant stock price jump. The focus now shifts to the regulatory approval process and the subsequent open offer to public shareholders, which will determine the final ownership structure of Novartis India.

FAQ

Q: Why did Novartis India's stock price increase significantly?
A: The stock surged 20% after its Swiss parent, Novartis AG, announced a deal to sell its 70.68% stake for $159 million, a move positively received by the market.

Q: Who is the new majority owner of Novartis India?
A: A consortium led by private equity firm ChrysCapital will become the new majority owner upon completion of the transaction.

Q: Is the deal finalized?
A: No, the transaction is still pending necessary regulatory approvals and the fulfillment of other conditions before it can be officially completed.

Source: Investing.com